Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LABT
LABT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LABT News
Virtual Investor Conferences Forum Highlights
Jun 26 2026
Globenewswire
Lakewood-Amedex Appoints New Scientific Advisor for iDFU Program
Jun 25 2026
PRnewswire
Agenda Announced for Life Sciences Virtual Investor Forum
Jun 23 2026
Globenewswire
New Patent Expands Global IP Footprint
Jun 22 2026
PRnewswire
New Patent Expands Global IP Footprint
Jun 22 2026
Newsfilter
Lakewood-Amedex Biotherapeutics Announces Presentation at Life Sciences Virtual Investor Forum
Jun 16 2026
PRnewswire
Lakewood-Amedex Expands Patent Portfolio with New Patents
May 27 2026
PRnewswire
Lakewood-Amedex Advances Nu-3 Towards Phase 2 Clinical Trial
May 18 2026
PRnewswire
Lakewood-Amedex Partners with PERI to Advance Nu-3 Clinical Trial
May 12 2026
PRnewswire
Lakewood-Amedex Announces Positive AMR Data for Nu-3 Antimicrobial
May 01 2026
Newsfilter
Lakewood-Amedex Appoints New Board Member to Strengthen Governance
Apr 28 2026
PRnewswire
Lakewood-Amedex Appoints New Board Member to Strengthen Governance
Apr 28 2026
Newsfilter
Lakewood-Amedex Completes Direct Listing on Nasdaq
Apr 27 2026
renaissancecapital
Lakewood-Amedex Biotherapeutics Listing Accelerates Development of Nu-3
Apr 24 2026
stocktwits
Lakewood-Amedex Biotherapeutics Goes Public on Nasdaq
Apr 24 2026
NASDAQ.COM
Lakewood-Amedex Biotherapeutics Begins Trading on Nasdaq
Apr 23 2026
Newsfilter
Show More News
